Zydus Lifesciences Ltd shares closed at ₹ 948.95 on NSE on Tuesday following the Q2 results, 2.4% lower than the previous day ...

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...

Investment in Research & Development (R&D) for the quarter amounted to ₹480 crore, representing 9.2% of the company's total revenue.

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

Zydus Lifesciences Ltd reports 13.7% profit increase in Q2 FY25, with revenues up 20% and strong growth momentum.

Dr. Alexander Dobranowski, Chief Executive Officer of HEALWELL, commented, "During the quarter, we delivered record revenue and gross profit, attributable to the growth in commercialization of our AI ...

According the company's statement, the company's Consumer business registered revenues of Rs. 4,87.5 crore, up 12 % y-o-y.

But deals like this are a regular occurrence for Boston Scientific, and the Marlborough company has the process down to, well ...

More than 300 alumni returned to Carnegie Mellon University in Qatar (CMU-Q), a Qatar Foundation (QF) partner university, to ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third quarter 2024 investor ...